The Sheraton Atlanta Hotel 165 Courtland Street NE Atlanta, GA 30303

clinicaltmssociety.org | 845-392-3238 | [email protected] Page 2016 Annual Meeting Atlanta, Georgia May 12-14, 2016 Table of Contents

President’s Welcome ………….………………………………………….……..……………………3 Annual Meeting Committee Welcome …………. ………………………...……………………….4 Clinical TMS Society Committees ……………………….………………………………………….5 On-Site Schedule At A Glance Thursday, May 12, 2016……..……………….….……………………………………….……..6 Friday, May 13, 2016….……………………………………………………………….………...7-8 Saturday, May 14, 2016…………………………………………………………………………9-10 Sheraton Hotel - Level 1 - Conference Map……………………………………………………….11 Poster Information…...……………………..……………………….……………………….………..12-13 Mayo Clinic/CME Instructions……………………………………………………………………….14-15 Faculty Biographies…………………………………………………………………………………...16-23 Notes……………………………………………………………………………………………………..24-26 Thank You to Our Sponsors & Exhibitors ……………………….….…………………….………27

Conference Wifi Wifi is available but is limited. Please only connect one device to the wifi during the conference. Passcode: CTMS2016

Clinicaltmssociety.org | brainstimjrnl.com | ce.mayo.edu

Page 2 2016 Annual Meeting Atlanta, Georgia President’s Welcome 2015-2016 Board of Directors Welcome to the 4th Annual Clinical TMS Society Educational Conference. Our President Annual Meeting Committee led by Todd Hutton has put together an all-star line Richard Bermudes, MD up of speakers to invigorate you and fuel your passion for transcranial magnetic Secretary stimulation (TMS). Our conference will provide 14 hours of CME featuring talks Rick Trautner, MD on the expanding evidence base for TMS for the treatment of a number of Treasurer neuropsychiatric conditions. I want to welcome our two keynote speakers Theodore S. Wirecki, MD Professor Anthony Barker, FIET, FIPEM and Sarah H. Lisanby, MD. Professor Officer at Large Barker led the group which invented the technique of TMS and has specialized Michelle Cochran, MD in a number of research areas during his NHS career, including the effects of Officer at Large electromagnetic fields on the body, electrical stimulation of nerves, Functional Mahmoud S. Okasha, MD Electrical Stimulation and medical device development. Dr. Lisanby, who now Director directs the NIMH division of translational research, is one of the leading Ian Cook, MD researchers in the area of neuromodulatory interventions for treating major Director depression, serving as a principal investigator on studies that range from basic Kim Cress, MD research through clinical trials. Director David Dunner, MD This year’s meeting of the Society includes TMS providers with extensive Director David Feifel, MD, PhD clinical and research experience from across the United States and the world. My hope is that as you attend this meeting you will not only reconnect with old Director William Gilmer, MD friends and colleagues in the field, but you will find new ways of optimizing the Director administration of TMS and learn about novel uses for this therapy. Geoffrey Grammer, MD Director A number of individuals have dedicated countless hours to the planning of this Eric Hollander, MD year’s meeting. A special thank you goes to the Annual Meeting Committee Director which included Todd Hutton, Michelle Cochran, Jay Gunkelman, Paul Croarkin, Todd Hutton, MD and Richard Pitch. The Society thanks Paige Hutton who volunteered Director numerous hours and worked with Todd to coordinate the meetings, contract Philip Janicak, MD with the hotel, and organize our vendor support and CME. Finally, a special Director thanks goes to Professional Exchange Service Corporation (PESC) staff, Kevin Kinback, MD Ashleigh Servadio, Marcel Bourdase and Matt Haas. The quality of this year’s Director conference reflects the team work of this group of individuals. Stefano Pallanti, MD, PhD

Director Last but not least I want to thank our meeting sponsors. Platinum sponsor- Alvaro Pascual-Leone, MD Neurostar, Gold sponsor-Brainsway, and Bronze sponsor-Magstim who Director provided levels of support that have made it possible to keep our meeting costs Tarique Perera, MD down for our members and in addition they have added to our program Director Murali Rao, MD offerings with industry sponsored symposium and trainings.

Director Saad Shakir, MD I warmly welcome you to our annual educational conference and encourage you to get involved with your Society! Director Leslie Smith, MD Director Ted Williams, MD Richard Bermudes, MD President, Clinical TMS Society Page 3 2016 Annual Meeting Atlanta, Georgia May 12-14, 2016 Annual Meeting Committee Welcome

It is with great pleasure that I welcome you to the 2016 Annual Meeting of the Clinical TMS Society. For me, the TMS Society meeting has been the highlight of the year for its fascinating content as well as a place to connect with colleagues. The annual meeting committee has been working hard for many months to build on this tradition and add to it in a way that reflects the exciting growth in the field of Transcranial Magnetic Stimulation. Our focus this year has been to make the annual meeting even more valuable to our Society members. First priority was to obtain CME credit for the meeting, which was successfully accomplished through a partnership with the Mayo Clinic. We brought even more content this year, expanding into two very full days of programing. We sought to address head on issues of relevance to members such as a comparison of the US FDA cleared devices, current clinical standards, as well as a look to the future of TMS. Sessions have evolved to include a variety of formats, including panel discussions meant to engage attendees, “breakout sessions” to focus on specific areas of interest, and scientific presentations from leaders in the field. This year brings the first time we have offered content specifically targeted to TMS technicians (and new physicians), as there is no other venue for ongoing technician education. We are pleased to see that members have responded to this as almost one quarter of our attendees are technicians. The faculty this year is excellent and comes from five continents. A very special highlight this year is our opening session with Professor Anthony Barker, FIET, FIPEM who was the first of the modern era to stimulate the brain with high powered electromagnets. Our Friday dinner address will be delivered by preeminent neuromodulation researcher Sarah Hollingsworth Lisanby MD, formerly chair of psychiatry at Duke and now at the National Institutes of Health. Many thanks go out to our sponsors from industry without whom the cost of this meeting to our members would have been much greater. Their unrestricted support has allowed us to bring to you a superior meeting experience, and we are truly appreciative. Planning this meeting spanned the transition from our beloved Nina Cudney, MS to PESC (Professional Exchange Service Corporation), our new professional managers, who have jumped right in to make the changeover go smoothly. I also want to thank my fellow committee members who have each brought special talents and many hours of effort to putting this meeting together, especially Michelle Cochran and Rick Pitch for their guidance from previous year’s meetings, Paul Croarkin for handling the poster session and CME, Jay Gunkelman for handling sponsors, exhibitors, and meeting logistics, our President, Richard Bermudes, MD for board leadership, and lastly my wife, Paige, who put in countless hours to make it all happen. We hope this meeting serves to advance and improve our individual skills and knowledge, as well as advance the field of TMS into the future.

Todd Hutton, MD Annual Meeting Committee Chair

Page 4 2016 Annual Meeting Atlanta, Georgia May 12-14, 2016 Clinical TMS Society Committees*

Annual Meeting Clinical Standards Insurance Todd Hutton, MD - Chair David Feifel, MD– Co-Chair Kevin Kinback, MD - Co-Chair Richard Bermudes, MD Dan Press, MD - Co-Chair Max Okasha, MD - Co-Chair Michelle Cochran, MD Richard Bermudes, MD Richard Bermudes, MD Paul Croarkin, DO Aaron Boes, MD Lane Cook, MD Jay Gunkleman Joel Crohn, Ph.D David Dunner, MD Richard Pitch, MD Todd Hutton, MD Mehmet Dokucu, MD, Ph.D Kevin Kinback, MD David Feifel, MD Karl Lanocha, MD Paul Gross, MD Shelly Menolascino, MD Karl Lanocha, MD Max Okasha, MD Aron Tendler, MD Johnny O'Reardon, MD Scott West, MD Tarique Perera, MD William Sauve, MD Scott West, MD

Legal & Business Membership Newsletter Editorial Board Tim Kriske - Co-Chair Eric Hollander, MD - Co-Chair David Feifel, MD - Chair/Editor Todd Hutton, MD - Co-Chair Stefano Pallanti, MD - Co-Chair Ted Williams, MD - Associate Editor Mitch Belgin, MBA David Feifel, MD James Barbee, MD Mark Heatwole Kenneth Goolsby, MD John Fleming, MD Vic Topo Kevin Kinback, MD Shelly Menolascino, MD Leslie Smith, MD

Outreach Research Kim Cress, MD - Chair David Dunner, MD - Co-Chair John Fleming, MD Tarique Perera, MD - Co-Chair Charles Hayden, MD Christina Demopulous, MD Bob Sammons, MD William Gilmer, MD Will Sauve, MD Geoff Grammer, MD Scott West, MD Paul Gross, MD Ted Williams, MD Todd Hutton, MD Phil Janicak, MD Kevin Kinback, MD Max Okasha, MD Robert Pollack, MD Irwin Rosenfeld, MD

*If you are interested in joining a committee, please email [email protected] or visit the Clinical TMS Society table in the exhibit room during the annual meeting! Page 5 2016 Annual Meeting Atlanta, Georgia May 12-14, 2016 Schedule At A Glance* THURSDAY, MAY 12, 2016 Room

Committee Meetings 4p-5p Legal Business & Ethics Committee Georgia 7 Co-Chairs: Tim Kriske and Todd Hutton, MD

Research Committee Meeting Georgia 8 Co-Chairs: David Dunner, MD and Tarique Perera, MD

5p–6p Clinical Standards Committee Georgia 7 Co-Chairs: David Feifel, MD and Daniel Press, MD

Outreach Committee Meeting Georgia 8 Chairperson: Kimberly Cress, MD

6p–8p Welcome Reception & Registration Check-In Garden Courtyard Sponsored by NeuroStar TMS Therapy (Level 2)

Page 6 2016 Annual Meeting Atlanta, Georgia May 12-14, 2016 Schedule At A Glance*

FRIDAY, MAY 13, 2016 ROOM

7a-8a Registration Opens Georgia 3/4

7a – 7:45a Membership Committee Meeting Capitol Ballroom Co- Chairs: Eric Hollander, MD and Stefano Pallanti, MD North

7a – 7:50a Breakfast & NeuroStar TMS Therapy Perspectives on Georgia 7/8 Adolescent Treatment Resistant Depression

General Program

8a – 9a Transcranial Magnetic Stimulation: Capitol Ballroom CME: 60 mins From Genesis to Clinical Application North Presented by: Professor Anthony Barker, FIET, FIPEM

9a – 10a From Bench to Bedside: Capitol Ballroom CME: 60 mins Translating rTMS Research Findings into Clinical Practice North Presented by: Jonathan Downar, MD, Ph.D., FRCPC

10a – 10:30a Coffee Break – Exhibit Hall Georgia 3/4

Brainsway Demo Session Georgia 5

10:30a – 12:30p An Examination of Current FDA Approved TMS Devices Capitol Ballroom CME: 120 mins Presenters Include: Prof. Angel V. Peterchev, Ph.D.; North Prof. Abraham Zangen, Ph.D., David Brock, MD, and Yordan Todorov, MSC Panelists: Johnny O’Reardon, MD, Karl Lanocha, MD, & Robert McMullen, MD Moderator: Geoffrey Grammer, MD

12:30p –1:30p *NEW* TMS Table Talks - Box Lunch With Discussion Georgia This networking luncheon is open seating with tables PreFunction designated with discussion topics. Find the topic that interests you and engage in lively conversation. - Sponsored by Brainsway

NeuroStar TMS Therapy Presentation - TMS Therapy Coil Design Georgia 7/8 Considerations

Brainsway Demo Session Georgia 5

1:30p – 2:30p Top Articles of the Year Capitol Ballroom CME: 60 mins Presented by: Z. Jeff Daskalaskis, MD North

2:30p – 3:15p Current Clinical Standards for TMS Capitol Ballroom CME: 45 mins Presented By: David Feifel, MD, Geoffrey Grammer, MD & North Tarique Perera, MD

Page 7 2016 Annual Meeting Atlanta, Georgia May 12-14, 2016

FRIDAY, MAY 13, 2016 ROOM

3:15p – 3:45p Coffee Break – Exhibit Hall Georgia 3/4

3:15p – 5p Brainsway Demo Sessions Georgia 5

3:45p – 4:30p General Membership & Board Election Results Capitol Ballroom North

4:30p-5:30p Insurance Committee Meeting Georgia 2 Co-Chairs: Max Okasha, MD and Kevin Kinback, MD

(Exhibit hall closed 5p – 5:30p for poster reception preparation)

5:30p – 7p Poster Session and Reception Georgia 3/4

7p – 9:30p Evening Dinner Session Capitol Ballroom CME: 60 mins President’s Address & Special Society Recognitions North Richard Bermudes, MD, Clinical TMS Society President

Keynote Address Capitol Ballroom Sarah Hollingsworth Lisanby, MD North

Page 8 2016 Annual Meeting Atlanta, Georgia May 12-14, 2016

SATURDAY, MAY 14, 2016 ROOM

7a - 8a Registration Opens Georgia 3/4

7a – 8a New Board Meeting Georgia 5

7a – 8a Breakfast & NeuroStar TMS Therapy Research Initiatives Georgia 7/8

General Program

8:15a – 9:15a Potential Neurological Indications for TMS Capitol Ballroom CME: 60 mins Presented by: Daniel Press, MD North

9:15a – 10:15a Long-term Outcomes with TMS Therapy: Capitol Ballroom CME: 60 mins A Review of Continuation and Maintenance Data North Presented by: Linda Carpenter, MD

10:15a –10:45a Coffee Break – Exhibit Hall Georgia 3/4

Breakouts

Track Key: a. Advanced / Expanded Application - Georgia 7/8 b. Business Development - Georgia 5 c. Clinical (MD’s & Technicians) - Georgia 2

10:45a–11:30a a. TMS: Adolescents, ADD, and Autism Georgia 7/8 CME: 45 mins Presented by: Paul Croarkin, DO

b. The Current Insurance Landscape and CPT Coding for TMS Georgia 5 Presented by: Richard Bermudes, MD

c. Transcranial Magnetic Stimulation: Consultation, Safety and Georgia 2 Patient Response Presented by: Kim Cress, MD

11:30a–12:15p a. TMS in the Treatment of PTSD Georgia 7/8 CME: 45 mins Presented by: F. Andrew Kozel, MD, M.S.C.R.

b. Contract Best Practices Georgia 5 Presented by: Jeremy Gimbel, MBA, CPA

c. Patient Management During TMS Treatment Georgia 2 Presented by: Stephanie Vergara, LVN & Lauren Valencia, LMSW

General Program

12:15p –1:30p Luncheon with International Presentations Capitol Ballroom CME: 75 mins Presented by: Michael Kabar, MD (Peru) & North Yu Kawaguchi, MD (Japan)

Brain Print Raffle drawing

Page 9 2016 Annual Meeting Atlanta, Georgia May 12-14, 2016

SATURDAY, MAY 14, 2016 ROOM

Track Key: a. Advanced / Expanded Application - Georgia 7/8 b. Business Development - Georgia 5 c. Clinical (MD’s & Technicians) - Georgia 2

Breakout Sessions 1:30p – 2:15p a. TMS in the Treatment of Tinnitus Georgia 7/8 CME: 45 mins Presented by: William Stubbeman, MD & Robert L. Folmer, Ph.D.

b. Surviving Medicare Georgia 5 Presented by: W. Scott West, MD

c. Customizing TMS Treatment: Finding the Treatment Georgia 2 Target & Treatment Parameters Presented by: Michelle Cochran, MD & Todd Hutton, MD

2:15p – 3p a. Symptom Measurement During TMS: The What, When, Georgia 7/8 CME: 45 mins and Why Presented by: Shawn M. McClintock, Ph.D., MSCS

b. Marketing and Digital Strategies Georgia 5 Presented by: Nina Cudney, MS

c. WORKSHOP: Customizing TMS Treatment: Finding Georgia 2 the Treatment Target & Treatment Parameters Presented by: Michelle Cochran, MD & Todd Hutton, MD

3p – 3:30p Coffee Break – Exhibit Hall Georgia 3/4

General Program

3:30p – 4:30p tDCS – A New Treatment for Depression? Capitol Ballroom CME: 60 mins Presented by: Colleen Loo, MD North

4:30p – 6p Emerging Technologies in TMS Capitol Ballroom Presentations by: M. Bret Schneider, MD - Multi-Coil TMS, North Michael Rohan, Ph.D - Low Field Magnetic Stimulation, and Nicholas Dogris, Ph.D - NeuroField Neurofeedback Moderator: Ian A. Cook, MD

6p Meeting Concluded– See you next year!

Page 10 2016 Annual Meeting Atlanta, Georgia May 12-14, 2016

Page 11 2016 Annual Meeting Atlanta, Georgia May 12-14, 2016 Posters* # Lead Author Title

Treatment of Unipolar, Non-Psychotic Major Depressive Disorder 1 Kimberly Cress, MD with Transcranial Magnetic Stimulation: Examining Acute and Long-Term Efficacy of TMS A Retrospective Analysis of Transcranial Magnetic Stimulation Right 2 Kimberly Cress, MD Dorsolateral Prefrontal Cortex Treatments for Patients with Generalized Anxiety Disorder Efficacy of Deep Transcranial Magnetic Stimulation In Patients 3 Aron Tendler, MD Whose Depression Is Resistant To Electroconvulsive Therapy

Deep Transcranial Magnetic Stimulation For Schizoaffective 4 Aron Tendler, MD Depressive Phase

5 Yu Kawaguchi, MD High frequency rTMS applied to right DLPFC

6 David Hanaway, MD Treatment of visual hallucinations in Lewy body dementia with rTMS.

Treatment of depression in chronic kidney disease (CKD) patients on 7 Nawfel Abdulameer, MD Dialysis

Comparison of Beam Technique and 5.5 Centimeter Rule for 8 James Halper, MD Determining Site of TMS Stimulation for Major Depressive Disorder

A Case Study Comparing Ketamine to Deep TMS – Direct 9 Shelly Menolascino, MD Observation of Immediate Effect vs. Durable Recovery Using QEEG

Deep Transcranial Magnetic Stimulation of the Anterior Cingulate 10 Abraham Zangen, PhD Cortex in Obsessive Compulsive Disorder Patients

Right Prefrontal Transcranial Magnetic Stimulation For Adults With 11 Abraham Zangen, PhD ADHD: Electrophysiological Correlates and Prognostic Biomarkers.

Transcranial Magnetic Stimulation Treatment of Depression Using a 12 William Stubbeman, MD 20 Hertz Theta Burst Pulse Pattern: A Consecutive Case Series

Changes in Resting-state Quantitative Electroencephalography (qEEG) and Symptom Severity During Repetitive Transcranial 13 Aimee M. Hunter, PhD Magnetic Stimulation (rTMS) Treatment in Major Depressive Disorder (MDD): Case-studies Retrospective evaluation of transcranial magnetic stimulation 14 Julia Hooker, BA maintenance treatment for depression in clinical practice Response to First Course of TMS Treatment for Depression Predicts 15 Michael Kelly, BA Subsequent Response

Page 12 2016 Annual Meeting Atlanta, Georgia May 12-14, 2016 Posters* # Lead Author Title

Comparison of TMS Outcomes in Complex Major Depressive 16 Laura Viner, PhD Disorder: Brainsway and Neurostar

17 Ahmed Z Elmaadawi, MD Does rTMS Create Thoughts of Suicide? A Case Report

Gender and Age as factors in response and remission of Depression 18 Azfar Malik, MD treated with Transcranial Magnetic Stimulation

Effectiveness of NeuroStar Transcranial Magnetic Stimulation (TMS) 19 David G. Brock, MD in Patients with Major Depressive Disorder with Postpartum Onset

Successful Treatment of Bipolar Disorder patients with Transcranial 20 Shashank Agarwal, MD Magnetic Stimulation

Persistent Genital Arousal Disorder - Case Report of Symptomatic 21 Shashank Agarwal, MD Relief of Symptoms with Transcranial Magnetic Simulation

Bilateral rTMS v. Unilateral rTMS: An Analysis of Comparative 22 Ryan Webler Effectiveness

Timing of Depressive Symptom Response to rTMS: An Analysis of 23 Ryan Webler Psychometric Scales

Reductions in depression and anxiety measures are correlated in 24 Kevin A. Caulfield patients receiving transcranial magnetic stimulation

* No CME Credit

Page 13

Page 14

Page 15 2016 Annual Meeting Atlanta, Georgia May 12-14, 2016 Faculty Bios

Anthony T. Barker, Ph.D, FIET, FIPEM - Professor Barker, “Tony” recently retired from the U.K. National Health Service after 38 years in the Sheffield Department of Medical Physics and Clinical Engineering. An engineer by training, he has specialized in a of number research areas during his NHS career, including the effects of electromagnetic fields on the body (both detrimental and therapeutic), electrical stimulation of nerves, Functional Electrical Stimulation and medical device development. Tony led the group which invented the technique of Transcranial Magnetic Stimulation, now widely used throughout the world for basic research, diagnosis and therapy, and also the group which developed the first self-optimizing, array-based FES stimulator for foot drop. He has led numerous professional committees and currently is the long-standing chairman of the Biological Effects of Low-Level Electromagnetic Fields Policy Advisory Group of the Institution of Engineering and Technology. Tony has an active interest in the public understanding of science and has given many public lectures including the Faraday lecture series, the Silvanus P. Thomson series and a Royal Institution Discourse.

Richard Bermudes, MD - Dr. Bermudes completed specialized training in transcranial magnetic stimulation (TMS) in February 2010, and was the first provider of TMS therapy for depression in the Sacramento, CA region. In 2013 Dr. Bermudes chaired the first annual meeting of the Clinical TMS Society and served as a founding board member. In 2015 he was elected president of the Clinical TMS Society. Dr. Bermudes is a recognized national speaker on TMS practice organization, insurance reimbursement and policy development. Dr. Bermudes has authored articles on cognitive therapy techniques, the metabolic syndrome, and medication-associated obesity. He is the principal editor of A Clinical Guide for Managing Metabolic Abnormalities in the Psychiatrically Ill: What Psychiatrists Need to Know (American Psychiatric Publishing, Inc., 2007).

David G. Brock, MD - Dr. Brock is the Medical Director of Neuronetics, reporting to the Chief Medical Officer. He is board certified in both Neurology, with added qualification in cerebrovascular disease, and in neurocritical care. He has over 15 years experience treating patients with complex neurological conditions. Prior to joining Neuronetics he was a neurologist on the faculty at Thomas Jefferson University, where he was associate director of the Stroke Center and an Institutional Review Board chairman. In addition to his work in neurovascular disease, Dr. Brock has an interest in electroencephalography and seizures in the ICU setting. He has been an investigator in numerous clinical trials and has published in the fields of stroke and neurocritical care. He is co-editor of Gray’s Clinical Neuroanatomy.

Linda L. Carpenter, MD - Dr. Carpenter completed her undergraduate degree in honors psychology at the University of Michigan, then worked in the Mood Disorders Research Program at the Western Psychiatric Institute in Pittsburgh, concurrently completing post-baccalaureate premedical coursework at the University of Pittsburgh. She obtained her M.D. from the University of Pennsylvania and went on to complete an internship in internal medicine, a residency program in psychiatry, and a clinical neuroscience research fellowship at Yale University.

Michelle R.M. Cochran, MD, FAPA - Dr. Cochran currently works in a private practice in Nashville. She has experience treating a variety of psychiatric conditions, using therapy, counseling, medicines, neuro-modulation, and holistic options. Dr. Cochran completed her medical training at the University of Louisville School of Medicine and received her postgraduate medical education at Vanderbilt University Medical Center in Nashville, Tennessee, where she completed a residency in Psychiatry. For over 20 years, she has been active on numerous advisory boards professionally and personally. Dr. Cochran and her staff have trained extensively in the use of repetitive Transcranial Magnetic Stimulation (rTMS) including training at Harvard, Duke and specific industry training. Dr. Cochran has spoken nationally on the use of rTMS in a clinical setting in industry and continuing education venues.

Page 16 2016 Annual Meeting Atlanta, Georgia May 12-14, 2016 Faculty Bios Ian Cook, MD - Dr. Cook is a Professor-in-Residence of Psychiatry and of Bioengineering at UCLA, where he has been on the faculty for over two decades and was the Founding Chief of the TMS Service in 2009. His research has focused largely on the development of biomarkers to guide treatment in mood disorders and of new therapeutics for treating psychiatric and neurological disorders. He has been elected a Distinguished Fellow of the American Psychiatric Association and a member of the Board of the Clinical TMS Society. In 2014 he began a leave of absence to serve as Chief Medical Officer of NeuroSigma, Inc., the company that licensed his patents on trigeminal nerve stimulation from UCLA. Dr. Cook earned his bachelor’s degree from Princeton University and his MD from the Yale School of Medicine before coming to UCLA for residency and research fellowship training.

Kimberly Cress, MD - In private practice in Psychiatry since January 2000, Dr. Cress brings her extensive experience for difficult to treat mental illnesses to the TMS Serenity Center located in Sugar Land, TX and serving the Greater Houston area. A graduate from the University of Texas Health Science Center, San Antonio Medical School, Dr. Cress’ vast experience includes treating patients with treatment refractory depression, anxiety disorders and bipolar disorders at the Mood Disorder Center at Baylor College of Medicine. She was also involved with a variety of clinical trials and is a co-author in several journal articles.

Paul Croarkin, DO - Dr. Croarkin completed clinical and research training with the Naval Medical Center San Diego and UT Southwestern Medical School. He is a Mayo Clinic Consultant and Associate Professor of Psychiatry and Psychology. His research efforts focus on understanding the neurobiology, optimal treatment and classification of mood disorders in children and adolescents. This includes studies of repetitive transcranial magnetic stimulation (rTMS) for adolescent major depressive disorder; collaborative clinical trials; studies of neurophysiology with magnetic resonance spectroscopy (MRS); and novel, single, and paired-pulse transcranial magnetic stimulation (TMS) paradigms. A central theme is investigating the role of gamma-aminobutyric acid (GABA) and glutamate neurotransmitter systems in early-onset mood disorders with the goal of informing safer and more effective biologic treatments.

Nina Cudney, MS - With an undergraduate degree in counseling and a graduate degree in health education, Nina’s true niche is right here in the field of mental health and overall wellness. Nina is a Wellness Coach and Freelance Writer and specializes in content marketing, branding and overall marketing strategies. Her goal is to assist others in the creation and delivery of a message that connects with as many people as possible.

Z. Jeff Daskalakis, MD - Dr. Daskalakis is a Professor of Psychiatry, Chief of the CAMH Mood and Anxiety Division and Temerty Chair in Therapeutic Brain Intervention. The Temerty centre uses brain stimulation to treat severe mental illness (e.g., depression, schizophrenia and obsessive compulsive disorder) and also studies important brain mechanisms such as plasticity to understand how these treatments work. He has received several national and international awards and distinctions, holds national and international peer-reviewed funding, is an editor for several key journals in the field, and has over 230 peer-reviewed publications.

Nicholas Dogris, Ph,D. - Dr. Dogris is a full time, California Licensed Psychologist working in private practice in the beautiful Eastern Sierra Mountain Range. He is BCIA board certified in neurofeedback and has over 12 years of experience in the field. He is the inventor and founder of NeuroField, Inc. which became a formal company in 2008. Dr. Dogris is trained in the assessment, diagnosis, and psychological treatment of adults, adolescents, and children. He has over 18 years of experience in the mental health field and has worked with diverse populations to include people with chronic mental illness, developmental disorders and geriatric disorders to include Alzheimer’s and Parkinson’s disease. Dr. Dogris is also trained in individual, family therapy, cognitive-behavioral and psychodynamic treatment modalities, QEEG, EEG Neurofeedback, Low Energy Neurofeedback System (LENS), hypnosis, EMDR, Page 17 2016 Annual Meeting Atlanta, Georgia May 12-14, 2016 Faculty Bios voice therapy, court mandated treatment of domestic violence, and play therapy. As well, Dr. Dogris is a Forensic evaluator for the Inyo and Mono County Superior Courts to include child custody, competency, and risk assessments.

Jonathan Downar, MD - Dr. Downar serves as the Director of the MRI-Guided rTMS Clinic at University Health Network, and also holds the position of Scientist at the Toronto Western Research Institute. He completed a BSc in biology at McGill University, followed by a PhD in neuroimaging at the University of Toronto with Dr. Karen Davis, before obtaining his medical degree from the University of Calgary in 2005. He then returned to Toronto for his psychiatry residency training, during which he also completed a research fellowship in neuroeconomics with Dr. Read Montague at Baylor College of Medicine. He currently holds an operating grant from CIHR as well as peer-reviewed funding from Brain Canada, the Klarman Foundation, and the Edgestone Foundation. His work has been published in Biological Psychiatry, Neuropsychopharmacology, Brain Stimulation, and Nature Neuroscience.

David Feifel, MD - Dr. Feifel is a Professor of Psychiatry at the University of California, San Diego where he is the founding Director of UCSD’s TMS program and the UCSD Center for Advanced Treatment of Mood and Anxiety Disorders. He is a board member of the Clinical TMS Society and also co-chairs its clinical standards committee as well as serves as the current editor of its official newsletter, “The Magnet.”

Robert Folmer, Ph.D. - Dr. Folmer earned B.A. and M.A. degrees in biology from San Francisco State University. He received his Ph.D. in Speech and Hearing Science from the University of California, San Francisco. At U.C.S.F., he conducted numerous EEG and evoked potential studies and evaluations for the Departments of Psychiatry, Neurology, Otolaryngology, and Neurosurgery. He also provided neurophysiological monitoring services during brain and spinal surgeries. In 1997, he joined the Department of Otolaryngology at Oregon Health & Science University where he maintains an appointment of Associate Professor. At OHSU, Dr. Folmer was part of the team that developed the Dangerous Decibels hearing loss prevention education program. He joined the NCRAR in 2007 and serves as Program Manager for the joint VA/Department of Defense Hearing Loss Prevention Initiative. His research projects/interests include transcranial magnetic stimulation (TMS) for relief of tinnitus; electrophysiological assessment of auditory processing; evaluation of auditory and cognitive functions in patients who have multiple sclerosis (MS), Parkinson Disease, or traumatic brain injury (TBI).

Jeremy Gimble, MBA, CPA - Mr. Gimble is the head of finance and operations for TMS Health Partners and speaking this weekend on payor relations, a challenging and evolving area of practice management. A former investment banker and venture capitalist turned healthcare executive. He has a lot of passion for creating strong operating discipline and a high-performing organization. With experiences in large multi-site healthcare providers like Davita and Gentiva, he loved making an impact in the mental health space having been the CFO of a public behavioral health organization in Phoenix and now in San Francisco with TMS Health.

Geoffrey Grammer, MD - A decorated Colonel with the United States Army, Dr. Grammer joined TMS NeuroHealth Centers as Chief Scientific Advisor where he develops TMS Therapy treatment protocols and oversees the training of staff physicians and technicians. Dr. Grammer created one of the very first TMS Therapy centers in the United States, and he is valued as a leading practitioner of TMS Therapy by his colleagues. Dr. Grammer completed two deployments to Iraq- the first, serving as Medical Director for the 785th Combat Stress Control Company, and the second as a psychiatrist at the Combat Support Hospital at Contingency Operating Base (COB) Speicher. He also deployed to Afghanistan as a psychiatrist at the Combat Support Hospital in Bagram. Page 18 2016 Annual Meeting Atlanta, Georgia May 12-14, 2016 Faculty Bios

Todd Hutton, MD - Dr. Hutton began his TMS practice in 2009 when he founded his first Southern California TMS Center location in Pasadena, CA. Since then, Dr. Hutton has expanded SoCal TMS to 6 locations throughout the greater Los Angeles area. Dr. Hutton serves on the Clinical TMS Society Board of Directors and is Chairman of this year’s Annual Meeting committee. A Fellow of the American Psychiatric Association, he is also an Associate Clinical Professor of Psychiatry at the USC Keck School of Medicine. Dr. Hutton received his Bachelors Degree in Biology in 1985, and his Doctor of Medicine in 1989 both from the University of California, Irvine. He completed his residency training in Psychiatry at Los Angeles County/USC Medical Center, where he spent his last year as Chief Resident.

Michael Kabar, MD - Dr. Kabar is a Peruvian-born physician who trained as a psychiatrist at the University of Maryland/Sheppard Pratt Hospitals and the San Mateo County Residency Program in Palo Alto, California. He is Board-certified and worked in the San Francisco Bay Area for almost 20 years in private practice at UC Berkeley as well as other facilities before returning to Peru in 2011 where he started a TMS-based practice.

Yu Kawaguchi, MD - Dr. Kawaguchi was born in Shizuoka Prefecture, Japan. Dr. Kawaguchi graduated from University of Tsukuba School of Medicine in March, 2006 and joined Shizuoka General Hospital in April 2006. From April 2008 through April 2011, Dr. Kawaguchi was part of the Shizuoka Prefectural Hospital Organization, including Shizuoka Psychiatric Medical Center, and Department of Internal Medicine (Nephrology Section, General Medicine, and Emergency Section). In April 2011, Dr. Kawaguchi joined the Department of Psychosomatic Medicine, Shinagawa Skin Clinic. In September 2013, Dr. Kawaguchi became Director of the Shinjuku Stress Clinic (formerly known as Shinjuku Mental Clinic). Dr. Kawaguchi is married with one child.

F. Andrew Kozel, MD, MSCR - Dr. Kozel is the Director of the TMS Clinic and Staff Psychiatrist in Mental Health and Behavioral Sciences (MH&BS) and Core Investigator in the HSR&D Center of Innovation on Disability and Rehabilitation Research (CINDRR) at the James A. Haley Veteran's hospital, as well as Courtesy Associate Professor, Department of Psychiatry and Behavioral Sciences, University of South Florida. Dr. Kozel's research uses brain imaging and brain stimulation to better understand and treat neuropsychiatric disorders with the focus of improving the lives of patients with these disorders.

Karl Lanocha, MD - Dr. Lanocha is a graduate of both Georgetown University and Jagiellonian University in Krakow, Poland. He completed his medical training at the University of Maryland School of Medicine, with a clinical clerkship at Guy’s Hospital in London, England. He then completed residency training in psychiatry at the Sheppard and Enoch Pratt Hospital in Baltimore and a Fellowship in Psychoanalytic Psychotherapy at the Tavistock Clinic in London, England . He was trained in Transcranial Magnetic Stimulation at the Berenson-Allen Center for Noninvasive Brain Stimulation at Harvard Beth Israel Deaconess Medical Center in Boston. He opened the first private TMS clinic in New England in 2009 and joined TMS Health Solutions in 2013.

Sarah Hollingsworth Lisanby, MD - Dr. Lisanby, a preeminent researcher in the fields of TMS and Neuromodulation, is currently the Director of the Division of Translational Research of the NIMH, and one of the Team Leads on the White House BRAIN Initiative. In these roles, she supervises a portfolio of research comprising approximately $400 million, and helps set a national agenda for research on mental illness, working to translate basic science into innovative treatment interventions. Previously she was the Chair of the Department of Psychiatry and Behavioral Sciences at Duke University School of Medicine, holding the J.P. Gibbons Professor of Psychiatry endowed chair, and founding Director of the Duke Division of Brain Stimulation and Neurophysiology. Duke is where she completed her undergraduate, medical, and residency training in psychiatry, serving as chief Page 19 2016 Annual Meeting Atlanta, Georgia Faculty Bios May 12-14, 2016 resident, before going to Columbia University where she was the Director of the Columbia Division of Brain Stimulation and Neuromodulation.

Colleen Loo, MD - Dr. Loo is a Professor of Psychiatry at the University of NSW, Founder and Director of the Sydney Neurostimulation Centre (SyNC) at the Black Dog Institute, consultant psychiatrist at the St George Hospital, and Director of ECT at Wesley Hospital in Sydney. She is a qualified psychiatrist and has a research doctorate. Professor Loo has established an internationally recognized research program investigating novel clinical treatments for psychiatric disorders, including Transcranial Magnetic Stimulation, transcranial Direct Current Stimulation and ketamine, and their effects on brain functioning. She conducted the first controlled trials in psychiatry of TMS, tDCS and ketamine in Australia. She has led and been involved in international multicenter trials. She has published over 130 papers, received grant funding as lead investigator from the Australian NHMRC, and US-based NARSAD and Stanley Foundations, and been part of a collaborative team awarded a large UK NHS/MRC grant.

Shawn McClintock, PhD, MSCS - Dr. McClintock is a Associate Professor in Psychiatry and Behavioral Sciences and Associate Research Professor in the Department of Psychology and Neuroscience at Duke University School of Medicine. His clinical research has focused on neuropsychological evaluation and clinical outcomes assessment of patients undergoing TMS and other neuromodulation treatments for major depression and other neuropsychiatric disorders.

Robert McMullen, MD - Dr. McMullen has held staff privileges at St. Luke’s-Roosevelt Hospital Center in New York City, St. Clare’s Hospital in New Jersey, Phelps Memorial Hospital Center in Sleepy Hollow, New York, Northern Westchester Hospital in Mt. Kisco, New York, and New York-Presbyterian Hospital. From 1990 until 2010, Dr. McMullen also served as Assistant Clinical Professor of Psychiatry at the Columbia University College of Physicians and Surgeons, where he taught in various capacities. For 14 years, Dr. McMullen taught and consulted at the Center for Oral, Facial, and Head Pain of the Columbia University College of Dental Medicine. Specializing in the treatment of TMJ (temporomandibular) syndrome and the associated atypical facial pain, Dr. McMullen contributed a chapter called “Pharmacologic Management of Psychiatric Disorder” in The Textbook of Temporomandibular Disorder, published in 1991. At the Columbia University College of Physicians and Surgeons, Dr. McMullen supervised second-year psychiatry students for a decade. Currently in private practice, psychiatrist Dr. McMullen has garnered a listing in Castle Connolly Medical, Ltd.’s Top Doctors: New York Metro Area for 10 consecutive years.

Johnny O’Reardon, MD - Dr. O’Reardon received his medical degree from University College Cork, in Ireland. He initially trained in primary care and is board certified in family medicine in Ireland and the UK. He completed his residency training in psychiatry at the University of Pennsylvania, and subsequent fellowships in psychopharmacology and in cognitive therapy. He was a Van Ameringen fellow at the Beck Institute for Cognitive Therapy and is a founding fellow of the Academy of Cognitive Therapy. Dr. O’Reardon is a Diplomate of the American Board of Psychiatry and Neurology. Dr. O’Reardon’s clinical and research interests include treatment resistant mood disorders, the development of novel neuromodulation therapies in psychiatry such as TMS, VNS, tDCS, and deep brain stimulation (DBS), cognitive therapy, and the night eating syndrome. He has served as an investigator in numerous clinical trials of therapeutic interventions including medications, cognitive therapy, TMS & VNS. He has made many contributions to the literature in his areas of interest in leading specialty journals including the Archives of General Psychiatry, Biological Psychiatry, Journal of Clinical Psychiatry, and the American Journal of Psychiatry. He has been teaching faculty at the APA, Institute of Psychiatric Services and International Society for ECT and Neurostimulation (ISEN) annual meetings in the area of mood disorders and neuromodulation treatments.

Page 20 2016 Annual Meeting Atlanta, Georgia Faculty Bios May 12-14, 2016

Tarique Perera, MD - Dr. Perera is a board certified psychiatrist, who trained Harvard Medical School and psychiatric residency program at Columbia University and the New York Psychiatric Institute. As the former Director of Preclinical research at the Division of Biological Psychiatry at NYSPI, Dr. Perera published extensively on the role of neurogenesis in the etiology and treatment of depression. While faculty at Columbia he received several awards and grants from the National Institute of Health (KO8 and RO1) and the New York Stem Cell Initiative. He lectures at Columbia's ECT course and is on the speaker panel of pharmaceutical companies. He practices medication management and psychotherapy at several locations in Connecticut and New York. Dr. Perera is the Founder and past President of the Clinical TMS Society. As the CEO of Contemporary Care he has 11 centers that offer TMS therapy in the northeast. Dr. Perera is the first author of the TMS guidelines of the society which was published in the Brain Stimulation Journal.

Angel V. Peterchev, Ph.D. - Dr. Peterchev is an Associate Professor in Psychiatry and Behavioral Sciences at Duke University. He directs the Brain Stimulation Engineering Lab (BSEL) which focuses on the development and modeling of devices and application paradigms for transcranial brain stimulation. Transcranial brain stimulation involves non-invasive delivery of fields (e.g., electric and magnetic) to the brain that modulate neural activity. Transcranial brain stimulation is increasingly used as a tool for brain research and a therapeutic intervention in neurology and psychiatry. His lab works closely with neuroscientists and clinicians to translate novel brain stimulation technology and optimize existing techniques. His lab is involved in the integration of transcranial brain stimulation with imaging modalities such as functional magnetic resonance imaging (fMRI) and electroencephalography (EEG), as well as the evaluation of the safety of device-device interactions, for example between transcranial stimulators and implants like deep-brain stimulation (DBS) systems. He also collaborates on projects related to circuit design and control of electrical energy converters.

Daniel Z. Press, MD - As the clinical director for the Center for Noninvasive Brain Stimulation at Beth Israel Deaconess Medical Center, Dr. Press directs a program that uses transcranial magnetic stimulation as a treatment modality and performed over 11,000 treatments for over 230 patients with medication refractory psychiatric and neurological conditions. TMS allows for modulation of brain circuitry with excellent anatomical resolution. TMS allows for measurement of neuroplasticity, and he has used this to study motor system function. Dr. Press has also studied the brain regions showing decreased perfusion in Alzheimer’s disease. Dr. Daniel Z. Press received his undergraduate degree from the University of Pennsylvania and his medical degree from the University of Connecticut School of Medicine. He trained in Neurology at the Harvard Longwood Neurology Training Program and did fellowship training in both Behavioral Neurology (1997-1999) and Movement Disorders (1999-2000).

Michael L. Rohan, Ph.D. - Dr. Rohan is a physicist at McLean Hospital and a Lecturer on Psychiatry at Harvard Medical School. He is the inventor of Low Field Magnetic Stimulation, a novel electromagnetic treatment for depression. Dr. Rohan started his career in the 1980s designing gradient systems and algorithms at Advanced NMR Systems for the development of the first commercial fMRI system. This work extended to studies of electromagnetic interactions and addressing safety concerns in the early fMRI protocols. Dr. Rohan came to McLean Hospital and Harvard Medical School in order to translate this experience into research in the field of psychiatry. At McLean, his primary focus is the development of LFMS and he has been developing LFMS as a treatment for mood disorders since its discovery in 2001. He directs the LFMS Group at McLean Hospital, which performs clinical and preclinical behavioral studies, imaging studies, and coil-based device design. He is active in the development of fMRI and EEG algorithms and analysis and collaborates with clinical and preclinical groups in studies of psychiatric disorders and substance abuse.

Page 21 2016 Annual Meeting Atlanta, Georgia Faculty Bios May 12-14, 2016

Bret Schneider, MD - Dr. Schneider specializes in neuromodulation technologies for interventional psychiatry, neurology and regenerative medicine. He earned a BA Cum Laude from Washington University in St. Louis, an MD degree from Rush University in Chicago, and graduated with a clinical residency in Psychiatry at UCLA. He subsequently completed a post-doctoral fellowship in neurosurgical stereotactic radiosurgery and a post-doctoral fellowship in Advanced Psychiatry, both at Stanford University. He then served as Staff Scientist in the laboratory of Karl Deisseroth, where he developed new technologies and techniques to enable precise and focal control of brain circuits. For more than two decades, Dr. Schneider has been an active medical device developer and holds numerous patents. He has designed and prototyped more than one hundred medical instruments, from computerized surgical navigation systems to implantable devices and biologics; technologies running across the gamut of medical disciplines. Among his developments, the Monoject Safety Syringe (today manufactured by Covidien) has sold more than 5 billion product units worldwide. Presently consulting for industry and academia, Dr. Schneider was recently Founder and Chief Medical Officer of Cervel Neurotech Inc., a venture capital-backed company built around his technologies for selective, non-invasive control of deep-brain circuits. As a board-certified psychiatrist and brain stimulation specialist, he maintains a clinical medical practice.

William F. Stubbeman, MD - Dr. Stubbeman graduated Magna Cum Laude from Princeton with a degree in Mechanical and Aerospace Engineering and received his MD from Columbia University. He began his training at UCLA as an Ear, Nose and Throat Surgeon specializing in auditory pathology but his growing interest in the brain caused him to switch his focus to Psychiatry. Upon completion of his residency in 1998, he held a two-year research fellowship at UCLA where he authored a number of scientific publications on early prediction of response to antidepressants and ECT. Dr. Stubbeman subsequently built a thriving psychiatry private practice in West Los Angeles specializing in treatment-refractory psychopharmacology. After realizing the potential of TMS to help patients that were beyond the reach of medications, he expanded his practice to include TMS treatment. An experienced and innovative TMS psychiatrist, Dr. Stubbeman has successfully used novel brain stimulation protocols for the treatment of depression and tinnitus.

Yordan Todorov, MSC - Mr. Todorov has an engineering background. He holds a Master’s Degree in Electronics and Microelectronics with subspecialty in Medical Equipment Manufacturing from Technical University in Varna. Presently, he works as a Vice President, Service and Support at MagVenture Inc – the US company which is a wholly owned subsidiary of MagVenture A/S – the manufacturer of the MagPro MagVita TMS Therapy system. Yordan built the startup operation and headquarters of the company in North America from the ground up. At the VP level, his responsibilities include planning, overseeing and ensuring efficient company operations in the North American market on all company levels such as marketing, logistics, technical and sales. He provides technical expertise and training to distributors on the functionality and service repairs related to MagVenture’s magnetic stimulation systems.

Lauren Valencia, LMSW - Ms. Valencia is a Licensed Master Social Worker and will receive her Licensed Clinical Social Worker license later this year. She graduated with her B.S. in Psychology and Criminology from Florida State University and when on to receive her Master's of Science in Social Work from the University of Tennessee. In therapy Lauren utilizes culturally competent, strengths-based approaches, CBT, and Motivational Interviewing. Lauren has been with the Nashville Center for Hope and Healing (NCHH) since 2013 as a Therapist & TMS Coordinator. As TMS Coordinator, Lauren sees patients daily to engage them in therapy during each session. Previously, she has worked with the Veteran's Health Administration and also in geriatrics, inpatient surgery, hospice, and addictions. Her diverse experiences enable her to discuss a variety of subject matter with the attention they deserve.

Page 22 2016 Annual Meeting Atlanta, Georgia May 12-14, 2016 Faculty Bios

Stephanie Vergara, LVN - Ms. Vergara, LVN joined Southern California TMS Center in 2011 and is currently the Senior TMS technician, supervising 6 locations. In addition to performing ongoing patient treatments, Ms. Vergara also manages all TMS technician operations and conducts ongoing quality control assessments for treatment protocol and patient management. Prior to joining SoCal TMS, Ms. Vergara spent 4 years at Cedar- Sinai Hospital in Los Angeles as a Psychiatric Nurse in the ECT lab. Ms. Vergara receives patient compliments on a regular basis for the quality and compassion she delivers to each and every patient. Ms. Vergara is currently working toward her Nurse Practitioner degree.

W. Scott West, MD - Dr. West has been practicing psychiatry in Nashville since 1986 when he finished his residency in psychiatry at Vanderbilt University Medical Center. Prior to that, he graduated Magna Cum Laude from The University of Tennessee, Knoxville and received his medical degree from The University of Tennessee Medical Center in Memphis. He has an outpatient practice where he treats adults dealing with mood disorders such as depression or anxiety, cognitive or attention problems, stress, relationship struggles and personality/ interpersonal issues. He is also Medical Director of the Neurobehavioral Unit at St. Thomas Hospital where his focus is on treating patients with problems associated with dementia or psychiatric problems with medical co-morbidities. He also serves on the clinical faculty in the Department of Psychiatry at Vanderbilt where he supervises residents.

Abraham Zangen, Ph.D. - Professor Zangen is the head of the brain stimulation and behavior lab in the department of life sciences at the Ben-Gurion University in Israel. He has developed unique deep transcranial magnetic stimulation coils for the treatments of depression, addiction and ADHD. The device he has developed for the treatment of depression was already approved by the FDA and other regulatory bodies, while other versions of his device are being tested for their efficacy in other psychiatric and neurological disorders. His early work in this field led to establishment of Brainsway, a company that commercializes the coils he developed with his colleagues. Prof. Zangen has published over 100 peer reviewed articles, reviews and book chapters, was rewarded with numerous personal prizes for his scientific achievements including the Medical Futures Innovation Award in London, The Juludan Prize at the Technion, and received several distinguished research grants including NIH, H2020 and ISF funding.

Page 23 2016 Annual Meeting Atlanta, Georgia May 12-14, 2016 NOTES

______

Page 24 2016 Annual Meeting Atlanta, Georgia May 12-14, 2016 NOTES

______

Page 25 2016 Annual Meeting Atlanta, Georgia May 12-14, 2016 NOTES

______

Page 26 2016 Annual Meeting Atlanta, Georgia May 12-14, 2016 We would like to thank Our Sponsors & Exhibitors for Making this Event Possible.

PLATINUM

NeuroStar TMS Therapy GOLD Brainsway

BRONZE Magstim, Inc. Exhibitors

 Brainsway  NeuroField

 Genomind, Inc.  NeuroStar TMS Therapy

 MAG and More  TMS Health Solutions,

 Magstim, Inc. LLC

 MagVenture  Xsalta Mental Health Marketing

Visit our exhibitors and enter to win a framed print ~ Georgia 3/4

Page 27

Page 28